Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke.

"Disclosures Dr Fonarow serves as a member of the Get With the Guidelines Steering Committee, receives research support from the National Institutes of Health, and is an employee of the University of California, which holds a patent on retriever devices for stroke. Dr Saver serves as a member of the Get With the Guidelines Science Subcommittee; as a scientific consultant regarding trial design and conduct to CoAxia, Concentric Medical, Talacris, Ferrer, Photothera, Brainsgate, Sygnis, and Ev3; received lecture honoraria from Ferrer; is an employee of the University of California, which holds a patent on retriever devices for stroke. Dr Smith is an unpaid volunteer on GWTG committees. Dr Broderick receives funding from the NINDS for multiple ongoing trials, receives study medications from Genentech for two ongoing NINDS studies, and has received payment as a consultant to Genentech and he has been reimbursed for travel to meetings by Genentech. Dr Kleindorfer none. Dr Sacco is immediate past president of the AHA. Dr Pan is a member of the DCRI, which serves as the AHA GWTG data-coordinating center. Dr Olson is a member of the DCRI, which serves as the AHA GWTG data-coordinating center and consultant to Bristol Myers Squibb-Sanofi. Dr Hernandez is a member of the DCRI, which serves as the AHA GWTG data-coordinating center. Dr Hernandez is a recipient of an AHA Pharmaceutical Roundtable grant and serves as a consultant to Johnson&Johnson and Amylin. Dr Peterson serves as PI of the Data Analytic Center for AHA GWTG. Dr Schwamm serves as chair of the AHA GWTG Steering Committee, serves as a consultant to the Massachusetts Department of Public Health."

"Sources of Funding The Get With The Guidelines®-Stroke (GWTG-Stroke) program is provided by the American Heart Association/American Stroke Association. The GWTG-Stroke program is currently supported in part by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson. GWTG-Stroke has been funded in the past through support from Boeringher-Ingelheim, Merck, Bristol-Myers Squib/Sanofi Pharmaceutical Partnership and the AHA Pharmaceutical Roundtable."